TAE Life Sciences

TAE Life Sciences is a biotechnology company developing biologically targeted radiation therapy for cancers that are difficult to treat. Its BNCT platform combines targeted boron-10 drugs with an accelerator-based neutron beam system, aiming to focus cancer-killing radiation at the cellular level while limiting effects on surrounding healthy tissue. The company is developing both the drug candidates and the neutron system; neither is currently available for commercial use.